BRAND_ANALYSIS #ILLUMINA HEALTH & PHARMA #5 OF 26 IN HEALTH & PHARMA INTERESTING

Illumina

· Public · Updated 04 Oct 2026 09:24 UTC
#133 of 1208 overall by tension · #5 of 26 in Health & Pharma
21 Interesting
The Silent Giant
Analysis

The genomics sequencer that turned science fiction into nasdaq reality. C=45, B=66, and +28.04% stock surge in 30 days signal a company riding the biotech wave before the inevitable correction. Sentiment at 0.50 is cautious because CRISPR fears remain.

IN THE NEWS (36 articles this week)
Illumina, Inc. (ILMN) Stock Price, News, Quote & History - Yahoo! Finance Canada
The Benchmark Matters: Evaluating TruPath Genome Beyond Individual Loci - Illumina
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off? - The Motley Fool
Cultural Score
45 / 100
Business Score
66 / 100
TENSION▁▂▂▂▁▁▁▁▂▂▂▁▂▂
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▄▅▅▅▅▄▅▅▅▅▅▃▅▅
Loading...
Wikipedia Momentum 15/40
News Presence 30/35
Search InterestRedistributed to other dimensions
Stock Momentum 30/30
Market Position 16/25
Revenue Growth 3/25
Earnings Health 17/20
Price$273.04
30d Change+28.0%
Market Cap$41.2B
Profit Margin18.3%
Illumina's tension is 21. Commerce outpacing culture. sociologyofcapitalism.com/brand/illumina
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/illumina.html" width="320" height="200" frameborder="0"></iframe>